Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05020470 · ClinicalTrials.gov registry record · NA

Pilot Testing A Theory-Driven Self-Management Intervention for Chronic Musculoskeletal Pain

A NA study of Chronic Musculoskeletal Pain, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
37
Enrollment target
2
Study locations

NCT05020470: Completed NA study of Chronic Musculoskeletal Pain, sponsored by Johns Hopkins University.

NCT05020470 is a NA study of Chronic Musculoskeletal Pain that has completed, run by Johns Hopkins University. The registered enrollment target is 37 participants, below the 433-participant average among 13 other Chronic Musculoskeletal Pain trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05020470, a NA study of Chronic Musculoskeletal Pain, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
2
Study locations

Study Summary

The proposed randomized control trial will evaluate auricular point acupressure (APA) treatment administered by the participant themselves with the use of a phone app on chronic musculoskeletal pain (CMP) outcomes. This study will randomly assign participants into three groups: (1) Self-guided mAPA (S-mAPA), (2) In-Person Training + mAPA (IP-mAPA), and (3) Usual Care Control (UC). EMA will be used to assess momentary pain outcomes and APA adherence. Data will be collected at pre- (T1), post-completion of intervention (T2), follow-ups at post 1M- (primary endpoint) (T3), 2M (T4), and 3M (secondary endpoint, long-term sustained effect) (T5) for a total of four assessments.

Primary Outcome

The Brief Pain Inventory-short form (BPI-sf) questionnaire includes assessment of pain location and multiple aspects of severity of pain, numbness, tingling, and stiffness, including worst, least, average pain, and present, as well as the interference with daily activities. The Brief Pain Inventory-short form (BPI-sf) has a total score ranging from 0 to 10 with higher scores indicating more pain.

Interventions

  • OTHER Usual Care
  • DEVICE Virtual Auricular Point Acupressure (APA)
  • OTHER In-Person Training

Study Locations (2)

Maryland

  • Johns Hopkins School of Nursing - Baltimore

Nevada

  • University of Nevada, Las Vegas - Las Vegas

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2021-09-22
Est. Completion 2022-08-11
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT05020470 record still lists

NCT05020470 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 433-participant average among 13 other Chronic Musculoskeletal Pain trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Chronic Musculoskeletal Pain appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.

NCT05020470 reports a single indexed study location in Maryland, Nevada.

Frequently Asked Questions

What is clinical trial NCT05020470 about?

NCT05020470 is a clinical study titled "Pilot Testing A Theory-Driven Self-Management Intervention for Chronic Musculoskeletal Pain". The proposed randomized control trial will evaluate auricular point acupressure (APA) treatment administered by the participant themselves with the use of a phone app on chronic musculoskeletal pain (CMP) outcomes. This study will randomly assign participants into three groups: (1) Self-guided mAPA...

What is the current status of trial NCT05020470?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2021-09-22. Estimated completion is 2022-08-11.

What conditions does trial NCT05020470 study?

This clinical trial studies the following conditions: Chronic Musculoskeletal Pain.

What interventions are being tested in trial NCT05020470?

The interventions under investigation include: Usual Care (OTHER), Virtual Auricular Point Acupressure (APA) (DEVICE), In-Person Training (OTHER).

Who is sponsoring clinical trial NCT05020470?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05020470 being conducted?

This trial has 2 study locations across Maryland, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Musculoskeletal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05020470's enrollment target sits among peer trials

37 11th of 13 higher than 3 of 13 other Chronic Musculoskeletal Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Musculoskeletal Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02800486 · 37 participants · Phase 2

    Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • NCT03173937 · 37 participants · Phase 1

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

  • NCT03295227 · 37 participants · Phase 1

    Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

  • NCT03401047 · 37 participants · Early Phase 1

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05020470, the US trial registry maintained by the National Library of Medicine. NCT05020470 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.